Marc Pocard

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

François Quénet, Dominique Élias, Lise Roca et al. · The Lancet Oncology · 2021 · 748 citations · Full text

Cytoreductive Surgery, Surgical Oncology, Prodige 7 +8

Factors Associated with Clinically Significant Anastomotic Leakage after Large Bowel Resection: Multivariate Analysis of 707 Patients

Arnaud Alvès, Yves Panís, Danielle Trancart et al. · World Journal of Surgery · 2002 · 504 citations

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis

Pierre‐Emmanuel Bonnot, Guillaume Piessen, Vahan Képénékian et al. · Journal of Clinical Oncology · 2019 · 387 citations

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech et al. · The Lancet · 2017 · 366 citations

Gastrointestinal Oncology, Greccar 2, Colorectal Surgery +8

Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer

Sylvia Julien, Ana Merino‐Trigo, Ludovic Lacroix et al. · Clinical Cancer Research · 2012 · 361 citations · Full text